CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2016	Dec. 31, 2015
Current assets
Cash	$ 4,224	$ 8,854
Prepaid drug product for testing	579	560
Other current assets	1,276	179
Total current assets	6,079	9,593
Fixed assets
Furniture, fixtures & equipment	123	123
Less Accumulated Depreciation	(72)	(51)
Property, Plant and Equipment, Net	51	72
Other assets
Technology licenses	2,500	2,500
Less Accumulated Amortization	(1,490)	(1,410)
Intangible Assets, Net (Excluding Goodwill), Total	1,010	1,090
Total Assets	7,140	10,755
Current liabilities
Accounts payable	123	54
Accrued expense	690	883
Total current liabilities	813	937
Total Liabilities	813	937
Shareholders' Equity
Preferred Stock, $.001 par value 10,000,000 shares authorized, no shares issued and outstanding	0	0
Common Stock, $.001 par value, 200,000,000 shares authorized 89,762,872 and 89,762,872 shares issued and outstanding as of 6/30/16 and 12/31/15, respectively	90	90
Additional paid in capital	35,430	35,112
Accumulated deficit	(29,193)	(25,384)
Total shareholders' equity	6,327	9,818
Total Liabilities & Shareholders' Equity	$ 7,140	$ 10,755